Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier: a case report

BACKGROUND: Homologous recombination deficiency is a marker of response to poly(ADP-ribose) polymerase inhibitors in different cancer types including ovary, prostate, and pancreatic cancer. To date, no report about poly(ADP-ribose) polymerase inhibitors has been published on cervical cancer. CASE PR...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Med Case Rep
Main Authors: Montero-Macias, Rosa, Koual, Meriem, Crespel, Céline, Le Frére-Belda, Marie Aude, Hélène, Hélène Blons, Nguyen-Xuan, Huyen-Thu, Garinet, Simon, Perkins, Géraldine, Balay, Vincent, Durdux, Catherine, Florin, Marie, Péré, Hélène, Bats, Anne-Sophie
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8063354/
https://ncbi.nlm.nih.gov/pubmed/33888155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-021-02767-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados